Front Desk: 469-391-0070
Menotropins: A Comprehensive Guide to Fertility Treatment
Summary of Key Points
Menotropins are injectable medications used to treat infertility and other reproductive conditions in both men and women. These hormone injections stimulate the ovaries in women and the testes in men to produce eggs and sperm, respectively. Menotropins are commonly used in assisted reproductive technology (ART) procedures, such as in vitro fertilization (IVF). Always consult your healthcare provider before starting or adjusting your dose of menotropin therapy.
Names of Medication
US Brand Name: Menopur (Menotropins)
US Brand Name: Repronex (Menotropins)
The generic name refers to the active ingredient in the medication, which remains consistent across all brands.
Pharmacologic Category
Category: Gonadotropins
Combination: Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH)
Dosing for Menotropin Therapy
Menotropins are prescribed to treat various reproductive conditions. The dosage and frequency depend on the specific condition being addressed. Always follow your doctor’s instructions and consult them before making any changes to your dose. You can also schedule a telemedicine appointment with one of our providers for personalized guidance on your fertility treatment.
Infertility (Female)
Initial dose: 75-150 IU injected subcutaneously or intramuscularly daily.
Frequency: Once daily.
Length of treatment: Typically 7-12 days, depending on ovarian response.
Hypogonadism (Male)
Initial dose: 75-150 IU injected subcutaneously or intramuscularly three times per week.
Frequency: Three times per week.
Length of treatment: Treatment may continue for several months, depending on sperm production response.
Ovarian Dysfunction
Initial dose: 75-150 IU injected subcutaneously or intramuscularly daily.
Frequency: Once daily.
Length of treatment: Treatment duration varies based on ovarian response, typically 7-12 days.
Polycystic Ovary Syndrome (PCOS)
Initial dose: 75 IU injected subcutaneously or intramuscularly daily.
Frequency: Once daily.
Length of treatment: Treatment duration depends on ovarian response, usually 7-12 days.
Anovulation
Initial dose: 75-150 IU injected subcutaneously or intramuscularly daily.
Frequency: Once daily.
Length of treatment: Typically 7-12 days, depending on ovarian response.
Male Factor Infertility
Initial dose: 75-150 IU injected subcutaneously or intramuscularly three times per week.
Frequency: Three times per week.
Length of treatment: Treatment may continue for several months, depending on sperm production response.
Testicular Failure
Initial dose: 75-150 IU injected subcutaneously or intramuscularly three times per week.
Frequency: Three times per week.
Length of treatment: Treatment may continue for several months, depending on sperm production response.
Endometriosis
Initial dose: 75-150 IU injected subcutaneously or intramuscularly daily.
Frequency: Once daily.
Length of treatment: Treatment duration varies based on ovarian response, typically 7-12 days.
Ovulatory Disorders
Initial dose: 75-150 IU injected subcutaneously or intramuscularly daily.
Frequency: Once daily.
Length of treatment: Typically 7-12 days, depending on ovarian response.
Assisted Reproductive Technology (ART)
Initial dose: 150 IU injected subcutaneously or intramuscularly daily.
Frequency: Once daily.
Length of treatment: Typically 7-12 days, depending on ovarian response.
Dosage Forms and Strengths
Menopur: 75 IU powder for injection
Repronex: 75 IU powder for injection
Contraindications for Menotropin Therapy
A contraindication refers to a specific situation or condition where a particular treatment or medication should not be used because it may be harmful to the patient. There are several conditions where menotropin therapy is not recommended.
Pregnancy: Menotropins should not be used during pregnancy, as they can harm the developing fetus. This medication is intended to stimulate ovulation, which is unnecessary once pregnancy has occurred.
Primary Ovarian Failure: Women with primary ovarian failure (when the ovaries stop functioning before age 40) should not use menotropins, as the medication will not effectively stimulate ovulation.
Uncontrolled Thyroid or Adrenal Dysfunction: If you have untreated or poorly managed thyroid or adrenal gland disorders, menotropins can worsen these conditions, making it unsafe to use.
Abnormal Uterine Bleeding: If you have unexplained or abnormal vaginal bleeding, menotropins should not be used until the cause is determined, as this could indicate a more serious condition, such as cancer.
Ovarian Cysts or Enlargement: Women with ovarian cysts or enlarged ovaries not related to polycystic ovary syndrome (PCOS) should avoid menotropins, as the medication could exacerbate these conditions.
Testicular Failure: Menotropins are not effective in men with primary testicular failure, a condition where the testes do not produce sperm or hormones properly.
Drug-to-Drug Interactions
Menotropins can interact with other medications, which may affect how well they work or increase the risk of side effects. It’s important to inform your healthcare provider about all medications you are currently taking. Some known drug interactions include:
Clomiphene (Clomid): This fertility medication may be used in combination with menotropins, but it can also increase the risk of ovarian hyperstimulation syndrome (OHSS), a potentially dangerous condition.
Gonadorelin (Factrel): This medication is used to test pituitary function and may interfere with the effects of menotropins.
Human Chorionic Gonadotropin (hCG) (Pregnyl, Ovidrel): hCG is often used alongside menotropins to trigger ovulation, but improper timing or dosing can lead to complications like OHSS.
Leuprolide (Lupron): This medication is used in fertility treatments to prevent premature ovulation, but it may require careful monitoring when used with menotropins.
Menotropins in Pregnancy
No, Menotropins should not be used during pregnancy. Their primary function is to stimulate ovulation, and once pregnancy is achieved, they are no longer necessary. In fact, continuing Menotropins during pregnancy could potentially harm the developing baby. If you suspect you are pregnant while undergoing Menotropin therapy, discontinue the medication immediately and consult your healthcare provider for guidance.
Menotropins While Breastfeeding
It is not recommended to use Menotropins while breastfeeding. There is limited information on whether Menotropins pass into breast milk or how they might affect a nursing infant. Additionally, breastfeeding can interfere with the hormonal balance needed for fertility treatments. If you are breastfeeding and considering fertility treatment, speak with your healthcare provider to explore the safest options for both you and your baby.
Estimated Cost of Menotropin Therapy
The cost of Menotropins can vary depending on the brand and dosage prescribed. Without insurance, the estimated cost for a 30-day supply using a GoodRX coupon typically ranges from $1,000 to $3,000. Prices may fluctuate based on the pharmacy and specific formulation. Be sure to check with your pharmacy and explore available discounts or coupons to help reduce the cost of your Menotropin therapy.
Possible Alternatives to Menotropins
Depending on your condition, alternative treatments or lifestyle changes may be beneficial. Always consult your healthcare provider before making any changes to your treatment plan. Below are some potential alternatives for various conditions:
- Infertility: Alternatives may include lifestyle changes such as maintaining a healthy weight, reducing stress, and avoiding smoking or excessive alcohol. Other medications, like Clomiphene (Clomid) or Letrozole (Femara), may also be considered.
- Hypogonadism: Testosterone replacement therapy may be an option for men with hypogonadism. Additionally, lifestyle changes, such as regular exercise and a balanced diet, can help manage symptoms.
- Ovarian Dysfunction: Hormonal therapies, including estrogen or progesterone supplements, may be used to regulate menstrual cycles and improve fertility.
- Polycystic Ovary Syndrome (PCOS): Lifestyle changes, such as weight loss and regular exercise, can improve symptoms. Medications like Metformin (Glucophage) or Letrozole (Femara) may also be prescribed.
- Anovulation: Clomiphene (Clomid) or Letrozole (Femara) are common alternatives to stimulate ovulation. Weight management and stress reduction can also help regulate ovulation.
- Male Factor Infertility: Lifestyle changes, such as quitting smoking, reducing alcohol intake, and maintaining a healthy weight, can improve sperm quality. In some cases, surgical interventions or assisted reproductive technologies like IVF may be recommended.
- Testicular Failure: Testosterone replacement therapy may be considered for men with testicular failure. However, this condition is often irreversible, and fertility treatments like sperm donation may be necessary.
- Endometriosis: Hormonal treatments, such as birth control pills, GnRH agonists, or progestins, may help manage symptoms. In more severe cases, surgery may be required to remove endometrial tissue.
- Ovulatory Disorders: Medications like Clomiphene (Clomid) or Letrozole (Femara) are often used to stimulate ovulation. Maintaining a healthy weight and reducing stress can also improve ovulatory function.
- Assisted Reproductive Technology (ART): In vitro fertilization (IVF) or intrauterine insemination (IUI) are common alternatives for couples struggling with infertility. These techniques can be used in conjunction with or as an alternative to Menotropins.
Recent Updates on Menotropins Research
Recent studies have focused on enhancing the safety and effectiveness of Menotropins in fertility treatments. One area of research is the development of individualized dosing protocols to minimize the risk of ovarian hyperstimulation syndrome (OHSS), a serious side effect of fertility medications. Researchers are also exploring the combination of Menotropins with other fertility treatments to improve success rates in assisted reproductive technologies like IVF. Ongoing studies are examining the long-term health outcomes of children born from fertility treatments involving Menotropins, with early results showing no significant differences in health compared to naturally conceived children.
As new research continues to emerge, it’s important to stay informed and discuss any concerns with your healthcare provider. If you have questions about Menotropins or your fertility treatment plan, our telemedicine providers are available to assist you at any time.
